Related Experiment Video
Updated: Aug 15, 2026
07:54
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Primary sclerosing cholangitis in children: a histologic follow-up study
L Arturo Batres1, Pierre Russo, Mark Mathews
1Division of Gastroenterology and Nutrition, The Children's Hospital of Philadelphia, 34th and Civic Center Boulevard, Philadelphia, PA 19104, USA.
Summary
Primary sclerosing cholangitis (PSC) in children often presents with advanced disease, necessitating liver transplantation. Histology at diagnosis does not reliably predict progression, and PSC recurrence post-transplant is a significant concern.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Autoimmune Liver Diseases
Background:
- Primary sclerosing cholangitis (PSC) is a rare, chronic liver disease.
- Limited data exists on pediatric PSC progression and long-term outcomes.
Purpose of the Study:
- To evaluate the clinical and histological features of pediatric PSC.
- To assess disease progression and outcomes, including liver transplantation and recurrence.
Main Methods:
- Retrospective review of medical records for pediatric PSC patients (1981-2001).
- Analysis of initial histology, disease progression, and post-transplant outcomes.
Main Results:
- Twenty pediatric patients diagnosed with PSC were identified.
- 50% had concurrent inflammatory bowel disease.
- Most presented with advanced fibrosis or cirrhosis; histology did not predict progression.
- Liver transplantation was required for 7/13 advanced cases and 3/7 earlier cases.
- PSC recurrence in the allograft occurred in 3/10 transplanted patients.
Conclusions:
- Pediatric PSC frequently presents insidiously with advanced disease.
- Histologic stage at diagnosis is not predictive of disease progression.
- Recurrence of PSC in liver allografts is a significant complication in children.
